Pharma giants from Johnson & Johnson to Novartis to Roche, looking for edges in speed and convenience, have unveiled self-injection options to replace intravenous infusions in the fields of cancer, ...
– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects our ...
In 2008, three years after Natalie Hayden was diagnosed with Crohn’s disease, she was hospitalized with an abscess the size of a tennis ball in her small intestine. Until then, Hayden had been ...
A new collaboration between Becton, Dickinson and Co. and Ypsomed will support the development of a 5.5-milliliter, glass, prefilled syringe designed for use with large-volume autoinjectors. The ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an expanded indication of self-administered subcutaneous furosemide for patients with HF. The ...
The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...
Abstract and Introduction Autonomic Reaction, the Anxiety Response, and Development of Phobic Symptoms Treatment of Self-Injection Anxiety Summary References Difficulties with self-injection, ...
Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results